Triple

T7110796
Position Surface form Disambiguated ID Type / Status
Subject Kefauver–Harris Drug Amendments of 1962 E165701 entity
Predicate shortName P43 FINISHED
Object Kefauver–Harris Amendments E165701 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Kefauver–Harris Amendments | Statement: [Kefauver–Harris Drug Amendments of 1962, shortName, Kefauver–Harris Amendments]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Kefauver–Harris Amendments
Context triple: [Kefauver–Harris Drug Amendments of 1962, shortName, Kefauver–Harris Amendments]
  • A. Kefauver–Harris Drug Amendments of 1962 chosen
    The Kefauver–Harris Drug Amendments of 1962 are U.S. federal regulations that strengthened drug safety and efficacy requirements, mandating proof of effectiveness and stricter oversight of pharmaceutical marketing and manufacturing.
  • B. Food and Drug Administration Amendments Act of 2007
    The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
  • C. Drug Price Competition and Patent Term Restoration Act of 1984
    The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
  • D. Food and Drug Administration Modernization Act of 1997
    The Food and Drug Administration Modernization Act of 1997 is a U.S. law that overhauled FDA regulatory procedures to speed the approval of drugs and medical devices while enhancing patient access to experimental therapies and modernizing agency operations.
  • E. Federal Food, Drug, and Cosmetic Act
    The Federal Food, Drug, and Cosmetic Act is a key U.S. law that authorizes the Food and Drug Administration to regulate the safety, labeling, and marketing of food, drugs, medical devices, and cosmetics.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c6888120f081908f8f01b201dc4a4c completed March 27, 2026, 1:39 p.m.
NER Named-entity recognition batch_69c6e5be09d881909988b5382ffa20ed completed March 27, 2026, 8:17 p.m.
NED1 Entity disambiguation (via context triple) batch_69c7a325a07c81909bd9a8f5d4461fb9 completed March 28, 2026, 9:45 a.m.
Created at: March 27, 2026, 2:43 p.m.